Gossamer Bio shareholders re-elect directors, ratify EY, approve say-on-pay

Gossamer Bio, Inc.

Faheem Hasnain re-elected as Class II director with 92.3M for, 26.7M withheld, 45.5M broker non-votes.
Russell Cox re-elected as Class II director with 89.0M for, 30.0M withheld, 45.5M broker non-votes.
Ratification of Ernst & Young as auditor for FY2026 passed: 163.2M for, 1.2M against, 41K abstain.
Advisory vote on named executive officer compensation approved: 111.3M for, 7.5M against, 137K abstain.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Gossamer Bio, Inc. shareholders approved Advisory approval of the compensation of the Company's named executive officers.

Proposal: say on pay
Outcome: passed

Exact text from the filing

The compensation of the named executive officers was approved, on an advisory basis, by the votes indicated: For Against Abstain Broker Non-Votes 111,286,550 7,545,502 137,461 45,450,098

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Gossamer Bio, Inc. shareholders approved Election of two Class II directors for a three-year term to expire at the 2029 annual meeting.

Proposal: director election
Outcome: passed

Exact text from the filing

The following two Class II directors were re-elected by the votes indicated: For Withheld Broker Non-Votes Faheem Hasnain 92,301,637 26,667,876 45,450,098 Russell Cox 88,975,980 29,993,533 45,450,098

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Gossamer Bio, Inc. shareholders approved Ratification of the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

Proposal: auditor ratification
Outcome: passed

Exact text from the filing

The selection was ratified by the votes indicated: For Against Abstain Broker Non-Votes 163,185,993 1,192,448 41,170 —

View on SEC.gov

406 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Gossamer Bio, Inc. filing history →

Source: SEC EDGAR

accession 0001728117-26-000042

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.